SEARCH

SEARCH BY CITATION

References

  • Agid Y., Javoy F. and Youdim M. (1973) Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6-hydroxydopamine lesion of the nigrostriatal pathway. Br. J. Pharmacol. 48, 175178.
  • Alexi T., Hughes P., Faull R. and Williams C. (1998) 3-Nitropropionic acid’s lethal triplet: cooperative pathways of neurodegeneration. Neuroreport 9, R57R64.
  • Ali S. F., LeBel C. P. and Bondy S. C. (1992) Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology 13, 637648.
  • Bagh M. B., Maiti A. K., Jana S., Banerjee K., Roy A. and Chakrabarti S. (2008) Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson’s disease. Free Radic. Res. 42, 574581.
  • Brouillet E., Guyot M. C., Mittoux V., Altairac S., Condé F., Palfi S. and Hantraye P. (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J. Neurochem. 70, 794805.
  • Chakraborty H., Sen P., Sur A., Chatterjee U. and Chakrabarti S. (2003) Age-related oxidative inactivation of Na+, K+-ATPase in rat brain crude synaptosomes. Exp. Gerontol. 38, 705710.
  • Demarest K. T., Smith D. J. and Azzaro A. J. (1980) The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons. J. Pharmacol. Exp. Ther. 215, 461468.
  • Fu Y., He F., Zhang S. and Jiao X. (1995) Consistent striatal damage in rats induced by 3-nitropropionic acid and cultures of arthrinium fungus. Neurotoxicol. Teratol. 17, 413418.
  • Galvan E. and Sitges M. (2004) Characterization of the participation of sodium channels on the rise in Na+ induced by 4-aminopyridine (4-AP) in synaptosomes. Neurochem. Res. 29, 347355.
  • Helkamaa T., Reenilä I., Tuominen R. K., Soinila S., Väänänen A., Tilgmann C. and Rauhala P. (2007) Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion. Neurochem. Int. 51, 412423.
  • Jana S., Maiti A. K., Bagh M. B., Banerjee K., Das A., Roy A. and Chakrabarti S. (2007) Dopamine but not 3,4-dihydroxy phenyl acetic acid (DOPAC) inhibits brain respiratory chain activity bu autoxidation and mitochondria catalyzed oxidation to quinone products: implications in Parkinson′s disease. Brain Res. 1139, 195200.
  • Khan F. H., Saha M. and Chakrabarti S. (2001) Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain. Brain Res. 895, 245249.
  • Khan F. H., Sen T., Maiti A. K., Jana S., Chatterjee U. and Chakrabarti S. (2005) Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson′s disease. Biochim. Biophys. Acta 1741, 6574.
  • Kuhn D. and Arthur R. (1998) Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons. J. Neurosci. 18, 71117117.
  • Kuhn D. and Arthur R. (1999) L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein. Brain Res. Mol. Brain Res. 73, 7884.
  • Ludolph A. C., He F., Spencer P. S., Hammerstad J. and Sabri M. (1991) 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18, 492498.
  • Maragos W. F., Jakel R., Pang Z. and Geddes J. W. (1998) 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions. Exp. Neurol. 154, 637644.
  • Maragos W. F., Tillman P. A., Chesnut M. and Jakel R. (1999) Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions. Brain Res. 834, 168172.
  • Maragos W., Young K., Altman C., Pocernich C., Drake J., Butterfield D., Seif I., Holschneider P., Chen K. and Shih J. (2004) Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice. Neurochem. Res. 29, 741746.
  • Paz M. A., Flückiger R., Boak A., Kagan H. M. and Gallop P. M. (1991) Specific detection of quinoproteins by redox-cycling staining. J. Biol. Chem. 266, 689692.
  • Raut A., Iglewski M. and Ratka A. (2006) Differential effects of impaired mitochondrial energy production on the function of mu and delta opioid receptors in neuronal SK-N-SH cells. Neurosci. Lett. 404, 242246.
  • Reenilä I., Tuomainen P., Soinila S. and Männistö P. T. (1997) Increase of catechol-O-methyltransferase activity in rat brain microglia after intrastriatal infusion of fluorocitrate, a glial toxin. Neurosci. Lett. 230, 155158.
  • Reynolds D., Carter R. and Morton A. (1998) Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington’s disease. J. Neurosci. 23, 1011610127.
  • Sablin S. O. and Ramsay R. R. (1998) Monoamine oxidase contains a redox-active disulfide. J. Biol. Chem. 273, 1407414076.
  • Sitges M. and Chiu L. M. (1995) w-Aga IVA selectively inhibits the calcium dependent fraction of the evoked release of [3H]GABA from synaptosomes. Neurochem. Res. 20, 10651071.
  • Sitges M. and Galindo C. (2005) Omega-agatoxin-TK is a useful tool to study P-type Ca2+ channel-mediated changes in internal Ca2+ and glutamate release in depolarised brain nerve terminals. Neurochem. Int. 46, 5360.
  • Sitges M., Reyes A. and Chiu L. M. (1994) Dopamine transporter mediated release of dopamine: role of chloride. J. Neurosci. Res. 39, 1122.
  • Sitges M., Nekrassov V. and Guarneros A. (2000) Simultaneous action of MK-801 (dizclopine) on dopamine, glutamate, aspartate and GABA release from striatum isolated nerve endings. Brain Res. 854, 4856.
  • Sitges M., Aldana B. I., Chiu L. M. and Nekrassov V. (2009) Characterization of phenytoin, carbamazepine, vinpocetine and clorgyline simultaneous effects on sodium channels and catecholamine metabolism in rat striatal nerve endings. Neurochem. Res. 34, 470479.
  • Trejo F., Nekrassov V. and Sitges M. (2001) Characterization of vinpocetine effects on DA and DOPAC release in striatal isolated nerve endings. Brain Res. 909, 5967.
  • Turner T. J., Adams M. E. and Dunlap K. (1992) Calcium channels coupled to glutamate release identified by w-Aga-IVA. Science 258, 310313.
  • Villarán R., Tomás-Camardiel M., de Pablos R., Santiago M., Herrera A., Navarro A., Machado A. and Cano J. (2008) Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production. Neurotoxicology 29, 244258.
  • Wu H., Chen K. and Shih J. (1993) Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines. Mol. Pharmacol. 43, 888893.